Amgen Inc. Company Profile

News Articles [ 588 Associated News Articles listed on BioPortfolio]

Amgen's New JV Fulfills Promise to Emphasize China

To date, Amgen, the US biotech drug company, has not had a major presence in China. In February of this year, Amgen said it would use a combination of partnerships and M&A to increase its particip...

Amgen

Amgen is a top biotechnology company based in Thousand Oaks, CA, USA. The company was founded in 1980. Amgen discovers, develops, manufactures and delivers innovative human therapeutics. Amgen was one...

Box: Amgen's c-Met experience

c-Met's highs and lows Amgen's c-Met experience Amgen Inc.'s rilotumumab improved survival in patients with gastric and gastroesophageal junction cancer whose tumors expressed high levels of c-Met, bu...

Amgen: Company profile

Summary Website: Amgen Headquarters: Thousand Oaks CA, USA Ticker Symbol: AMGN (Nasdaq Stock Exchange) AMG (Frankfurt Stock Exchange) SEC Link: Amgen Subsidiaries: Abgenix Alantos Pharmaceuticals...

TEXT-Fitch rates Amgen senior notes 'BBB'

Sept 10 - Fitch Ratings has assigned a 'BBB' rating to Amgen Inc.'s (Amgen) proposed issuance of euro notes due 2019 and sterling notes due 2029. Proceeds of the new debt are expected to be used for...

Amgen hebt erneut Jahresprognosen an, wieder starkes Quartal

Robert A. Bradway, CEO Amgen (Bild: Amgen) Thousand Oaks - Der weltgrösste Biotechkonzern Amgen tut es schon wieder: Erneut hebt das Unternehmen seine Jahresprognosen nach einem überraschend starke....

Amgen closes $315M buyout of KAI Pharmaceuticals

Amgen Inc. said Thursday it completed its acquisition of KAI Pharmaceuticals for $315 million.Amgen agreed to buy KAI in April. The South San Francisco, Calif., company is developing an experimental...

Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing

Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesper...

Drugs and Medications [ 13 Associated Drugs and Medications listed on BioPortfolio]

Nplate [Amgen Inc]

These highlights do not include all the information needed to use Nplate safely and effectively. See full prescribing information for Nplate. Nplate (romiplostim)For subcutaneous injection Initial U.S...

Neulasta [AMGEN INC]

These highlights do not include all the information needed to use Neulasta safely and effectively. See full prescribing information for Neulasta. Neulasta (pegfilgrastim) injection, for subcutaneous u...

Neulasta [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Neulasta safely and effectively. See full prescribing information for Neulasta.Neulasta (pegfilgrastim) injection, for subcutaneous us...

Sensipar [Amgen, Inc]

These highlights do not include all the information needed to use Sensipar safely and effectively. See full prescribing information for Sensipar. Sensipar (cinacalcet) TabletsInitial U.S. Approval: 20...

Xgeva [AMGEN]

These highlights do not include all the information needed to use XGEVA™ safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab)injection, for subcutaneous useInitial U...

PubMed Articles [ 102 Associated PubMed Articles listed on BioPortfolio]

Development towards rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process.

Erratum to: Enhancing and Sustaining AMG 009 Dissolution from a Matrix Tablet Via Microenvironmental pH Modulation and Supersaturation.

The discovery of an orally efficacious positive allosteric modulator of the calcium sensing receptor containing a dibenzylamine core.

The discovery of a series of novel and orally efficacious type II calcimimetics, developed from the lead compound 1, is described herein. Compound 22 suppressed plasma PTH levels relative to vehicle w...

Palladium-Catalyzed Coupling of Aldehyde-Derived Hydrazones: Practical Synthesis of Triazolopyridines and Related Heterocycles.

Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1).

Cation exchange chromatography of an aglycosylated IgG1 resulted in two distinct peaks during gradient elution. The early eluting peak contained

Clinical Trials [ 9 Associated Clinical Trials listed on BioPortfolio]

An Open Label Treatment Extension Study of AMG 706

This is an extension study to provide ongoing treatment with AMG 706 monotherapy for subjects with solid tumors who have completed the planned duration of AMG 706 treatment on a separate A...

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

The purpose of this study is to assess the safety, tolerability, and utility of AMG 531 unit dosing (µg) in thrombocytopenic subjects with ITP.

Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

The purpose of this study is to collect local laboratory data on immunoreactive parathyroid hormone (iPTH), calcium and phosphorus levels and estimated glomerular filtration rate (GFR) at...

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

5-Drug Combination Chemotherapy with Hematologic Toxicity Attenuation. EPOCH: Etoposide, VP-16, NSC-141540; Prednisone, PRED, NSC-10023; Vincristine, VCR, NSC-67574; Cyclophosphamide, CTX...

An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer

The purpose of this study is to describe the safety and tolerability of up to 5 years (ie, 3 years under the 20040138 Amgen study and 2 years on this study) denosumab administration as me...

Companies [ 39 Associated Companies listed on BioPortfolio]

Amgen Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bri...

Amgen, Inc.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bri...

Amgen

The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live...

Amgen AB

Amgen är ett världsledande bioteknologiskt läkemedelsföretag. Genom vetenskapliga upptäckter och innovationer har företaget under 25 års tid bidragit till att radikalt förbättra människors l...

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s li...